Literature DB >> 34170453

Marked Increase in Sales of Erectile Dysfunction Medication During COVID-19.

Inmaculada Hernandez1, Zeynep Gul2, Walid F Gellad3, Benjamin J Davies2.   

Abstract

Entities:  

Year:  2021        PMID： 34170453     DOI： 10.1007/s11606-021-06968-2

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  4 in total

1.  Risk of Ocular Adverse Events Associated With Use of Phosphodiesterase 5 Inhibitors in Men in the US.

Authors:  Mahyar Etminan; Mohit Sodhi; Frederick S Mikelberg; David Maberley
Journal:  JAMA Ophthalmol       Date:  2022-05-01       Impact factor: 8.253

2.  COVID-19 Infection Is Associated With New Onset Erectile Dysfunction: Insights From a National Registry.

Authors:  Kevin Y Chu; Sirpi Nackeeran; Laura Horodyski; Thomas A Masterson; Ranjith Ramasamy
Journal:  Sex Med       Date:  2021-12-15       Impact factor: 2.491

Review 3.  The adverse impact of COVID-19 on men's health.

Authors:  Justin M Dubin; Nelson E Bennett; Joshua A Halpern
Journal:  Curr Opin Urol       Date:  2022-03-01       Impact factor: 2.309

4.  Exploring the adult sexual wellbeing and behavior during the COVID-19 pandemic. A systematic review and meta-analysis.

Authors:  Iraklis Mourikis; Ioulia Kokka; Elli Koumantarou-Malisiova; Konstantinos Kontoangelos; George Konstantakopoulos; Charalabos Papageorgiou
Journal:  Front Psychiatry       Date:  2022-08-18       Impact factor: 5.435
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.